Immunohistochemical analysis of colorectal cancer with gastric phenotype: Claudin-18 is associated with poor prognosis

Pathology International

Volumn 60, Issue 10, 2010, Pages 673-680

  Matsuda, Miho ^a   Sentani, Kazuhiro ^a   Noguchi, Tsuyoshi ^b   Hinoi, Takao ^a   Okajima, Masazumi ^a   Matsusaki, Keisuke ^c   Sakamoto, Naoya ^a   Anami, Katsuhiro ^a   Naito, Yutaka ^a   Oue, Naohide ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c Hofu Institute of Gastroenterology   (Japan)

Author keywords

claudin 18; colorectal cancer; gastric phenotype; MUC5AC; prognosis

Indexed keywords

CLAUDIN 18; CLAUDIN 3; CLAUDIN 4; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; KI 67 ANTIGEN; MUCIN 2; MUCIN 5AC; MUCIN 6; PROTEIN P53; TRANSCRIPTION FACTOR CDX2;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL MEMBRANE; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE LOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77956863080     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02587.x     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96.
2. Gumbiner BM. Carcinogenesis: A balance between beta-catenin and APC. Curr Biol 1997 7 : 443 6.
3. Kuwai T, Kitadai Y, Tanaka S et al. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. Oncol Rep 2004 12 : 1033 7.
4. Oue N, Kuniyasu H, Noguchi T et al. Serum concentration of Reg IV in patients with colorectal cancer: Overexpression and high serum levels of Reg IV are associated with liver metastasis. Oncology 2007 72 : 371 80.
5. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001 2 : 285 93.
6. Niimi T, Nagashima K, Ward JM et al. claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol Cell Biol 2001 21 : 7380 90.
7. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 2006 208 : 633 42.
8. Sahin U, Koslowski M, Dhaene K et al. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res 2008 14 : 7624 34.
9. Zwiers A, Fuss IJ, Leijen S, Mulder CJ, Kraal G, Bouma G. Increased expression of the tight junction molecule claudin-18 A1 in both experimental colitis and ulcerative colitis. Inflamm Bowel Dis 2008 14 : 1652 9.
10. Sentani K, Oue N, Tashiro T et al. Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. Am J Surg Pathol 2008 32 : 1182 9.
11. Mees ST, Mennigen R, Spieker T et al. Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: Upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int J Colorectal Dis 2009 24 : 361 8.
12. Ueda J, Semba S, Chiba H et al. Heterogeneous expression of claudin-4 in human colorectal cancer: Decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis. Pathobiology 2007 74 : 32 41.
13. Matsuda Y, Semba S, Ueda J et al. Gastric and intestinal claudin expression at the invasive front of gastric carcinoma. Cancer Sci 2007 98 : 1014 9.
14. Kim YS, Gum J Jr., Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J 1996 13 : 693 707.
15. Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990 40 : 494 504.
16. Yoshikawa A, Inada Ki K, Yamachika T, Shimizu N, Kaminishi M, Tatematsu M. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998 1 : 134 41.
17. Tajima Y, Yamazaki K, Nishino N et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. Br J Cancer 2004 91 : 1342 8.
18. Hollingsworth MA, Swanson BJ. Mucins in cancer: Protection and control of the cell surface. Nat Rev Cancer 2004 4 : 45 60.
19. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004 23 : 77 99.
20. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001 48 : 526 35.
21. Tatsumi N, Kushima R, Vieth M et al. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms. Virchows Arch 2006 448 : 756 62.
22. Femia AP, Tarquini E, Salvadori M et al. K-ras mutations and mucin profile in preneoplastic lesions and colon tumors induced in rats by 1,2-dimethylhydrazine. Int J Cancer 2008 122 : 117 23.
23. Kocer B, McKolanis J, Soran A. Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma. BMC Gastroenterol 2006 6 : 4.
24. Chawengsaksophak K, James R, Hammond VE, Kontgen F, Beck F. Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 1997 386 : 84 7.
25. Kaimaktchiev V, Terracciano L, Tornillo L et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 2004 17 : 1392 9.
26. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System.
27. Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumors, 6th edn.
28. Mizoshita T, Tsukamoto T, Nakanishi H et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: Relationship with prognosis. J Cancer Res Clin Oncol 2003 129 : 727 34.
29. Oue N, Mitani Y, Aung PP et al. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. J Pathol 2005 207 : 185 98.
30. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966 50 : 163 70.
31. Hough CD, Sherman-Baust CA, Pizer ES et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000 60 : 6281 7.
32. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 2005 65 : 7378 85.
33. Hoevel T, Macek R, Swisshelm K, Kubbies M. Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 2004 108 : 374 83.
34. Michl P, Barth C, Buchholz M et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003 63 : 6265 71.
35. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: Expression in normal and neoplastic tissues. BMC Cancer 2006 6 : 186.
36. Itzkowitz SH, Present DH. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005 11 : 314 21.
37. Yano K, Imaeda T, Niimi T. Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells. Am J Physiol Gastrointest Liver Physiol 2008 294 : 336 43.
38. Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. Scand J Gastroenterol 2008 43 : 25 33.
39. Yao T, Tsutsumi S, Akaiwa Y et al. Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 2001 92 : 755 61.
40. Biemer-Huttmann AE, Walsh MD, McGuckin MA et al. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem 1999 47 : 1039 48.
41. Buisine MP, Janin A, Maunoury V et al. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 1996 110 : 84 91.
42. Bartman AE, Sanderson SJ, Ewing SL et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 1999 80 : 210 18.
43. Myerscough N, Sylvester PA, Warren BF et al. Abnormal subcellular distribution of mature MUC2 and de novo MUC5AC mucins in adenomas of the rectum: Immunohistochemical detection using non-VNTR antibodies to MUC2 and MUC5AC peptide. Glycoconj J 2001 18 : 907 14.
44. Mallo GV, Rechreche H, Frigerio JM et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997 74 : 35 44.
45. Hinoi T, Tani M, Lucas PC et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001 159 : 2239 48.
46. Bonhomme C, Duluc I, Martin E et al. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 2003 52 : 1465 71.
47. Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem 2003 278 : 44608 16.
48. Satake S, Semba S, Matsuda Y et al. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma. Pathol Int 2008 58 : 156 63.
49. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer 2008 122 : 1253 60.
50. Tsukamoto T, Inada K, Tanaka H et al. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: Inverse correlation during progression from gastric/intestinal- mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 2004 130 : 135 45.
51. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007 50 : 113 30.
52. Hoos A, Urist MJ, Stojadinovic A et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001 158 : 1245 51.